News
Bafna Pharmaceuticals standalone net profit rises 119.55% in the September 2026 quarter
11-Nov-2026 | 17:59
Sales rise 34.40% to Rs 47.67 crore
Net profit of Bafna Pharmaceuticals rose 119.55% to Rs 6.85 crore in the quarter ended September 2026 as against Rs 3.12 crore during the previous quarter ended September 2025. Sales rose 34.40% to Rs 47.67 crore in the quarter ended September 2026 as against Rs 35.47 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 47.67 | 35.47 | 34 |
| OPM % | 18.06 | 12.04 | - |
| PBDT | 8.72 | 4.59 | 90 |
| PBT | 6.85 | 3.12 | 120 |
| NP | 6.85 | 3.12 | 120 |
Powered by Capital Market - Live News